[go: up one dir, main page]

BR9905648A - Mediador de androgênio oticamente puro - Google Patents

Mediador de androgênio oticamente puro

Info

Publication number
BR9905648A
BR9905648A BR9905648-8A BR9905648A BR9905648A BR 9905648 A BR9905648 A BR 9905648A BR 9905648 A BR9905648 A BR 9905648A BR 9905648 A BR9905648 A BR 9905648A
Authority
BR
Brazil
Prior art keywords
mediator
optically pure
pure androgen
androgen
stereoisomer
Prior art date
Application number
BR9905648-8A
Other languages
English (en)
Inventor
Thomas George Gant
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9905648A publication Critical patent/BR9905648A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Processo de Invenção: <B> "MEDIADOR DE ANDROGêNIO OTICAMENTE PURO".<D> Esta invenção refere-se a um mediador de androgênio oticamente puro, a composições farmacêuticas contendo o estereoisómero e a utilização do estereoisómero para ajudar na prevenção e restabelecimento de, por exemplo, declínio na massa e força muscular relacionado com a idade e no tratamento de condições que se apresentam com baixa massa óssea em mamíferos, incluindo ser humanos.
BR9905648-8A 1998-11-20 1999-11-18 Mediador de androgênio oticamente puro BR9905648A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10927798P 1998-11-20 1998-11-20

Publications (1)

Publication Number Publication Date
BR9905648A true BR9905648A (pt) 2001-03-20

Family

ID=22326804

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9905648-8A BR9905648A (pt) 1998-11-20 1999-11-18 Mediador de androgênio oticamente puro

Country Status (5)

Country Link
US (1) US6083956A (pt)
EP (1) EP1002799A1 (pt)
JP (1) JP3294574B2 (pt)
BR (1) BR9905648A (pt)
CA (1) CA2290332C (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
FR2825268B1 (fr) * 2001-05-31 2004-09-17 Oreal Composition cosmetique comprenant des particules de carbonate de calcium et des agents de conditionnement
ES2291507T3 (es) * 2001-10-19 2008-03-01 MERCK &amp; CO., INC. Moduladores de receptor de androgenos y procedimientos de uso de los mismos.
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
US20060183724A1 (en) * 2005-02-03 2006-08-17 Diliberti Charles E Compositions of unconjugated estrogens and methods for their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693647A (en) * 1994-12-22 1997-12-02 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods

Also Published As

Publication number Publication date
CA2290332C (en) 2003-11-11
US6083956A (en) 2000-07-04
JP2000159771A (ja) 2000-06-13
CA2290332A1 (en) 2000-05-20
EP1002799A1 (en) 2000-05-24
JP3294574B2 (ja) 2002-06-24

Similar Documents

Publication Publication Date Title
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
BR9714155A (pt) Prevenção da perda e reposição da massa óssea por certos agonistas de prostaglandina.
AP9801269A0 (en) Prostaglandin agonists.
PT1233770E (pt) Compostos de fosfonato
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
EP0911321A3 (en) Compounds for the treatment of osteoporosis
BR9910570A (pt) Aparelho para o tratamento de distúrbios de tecido e/ou das juntas
BR9812837A (pt) Processo para fazer um composto, e, composto
GT199700009AA (es) Terapia combinada para la osteoporosis
BR9712285A (pt) Tetrafosfonato bicìclico de trianidridas
BR0318600A (pt) conjunto implantável para osteossìntese, e, conjunto com pelo menos duas placas de osteossìntese e parafusos ósseos
BR9809079A (pt) Sistema de entrega de implante
BR9913156A (pt) Composição e processo para condicionamento, clareamento e realce do cabelo
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
BR9806145A (pt) Processo para derivatização seletiva de taxanos
BR9712824A (pt) Composição oftálmica de fator neurotrófico, agente de tratamento de desordem funcional do nervo ótico e método para tratamento de desordem funcional do nervo ótico
BR0211011A (pt) Composição, método para fornecimento de estabilidade fìsica, método para tratamento de fibras queratìnicas e kit de múltiplos compartimentos
BR9913705A (pt) Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
BR0306738A (pt) Processo e aparelho para preparar partìculas cristalinas de uma substância, população de partìculas, e, composição farmacêutica
BR9713574A (pt) Processo para a desinfecção de instrumentos.
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
BR9813514A (pt) Agente para tratamento de fibras queratìnicas
BR9808923A (pt) Composto, e, processo para fazer o mesmo
BR9905648A (pt) Mediador de androgênio oticamente puro

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DA(S) 8A E 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 1986 DE 27/03/2009.